Market Major Trends - New High: Horizon Pharma, Norfolk Southern, Delphi Automotive, and Solazyme

   Market Major Trends - New High: Horizon Pharma, Norfolk Southern, Delphi
                           Automotive, and Solazyme

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

LONDON, March 14, 2014

LONDON, March 14, 2014 /PRNewswire/ --

On Tuesday, March 11, 2014, the NASDAQ Composite finished at 4,307.19, down
0.63%. The Dow Jones Industrial Average closed the session at 16,351.25, down
0.41% and the S&P 500 ended the day at 1867.63, lower by 0.51%. The losses
were broad based as nine out of ten sectors ended the session in negative.
Investor-Edge.com looks at some of the equities that hit a new 52-week high
during the last session. These include Horizon Pharma Inc. (NASDAQ:HZNP),
Norfolk Southern Corporation. (NYSE:NSC), Delphi Automotive PLC (NYSE: DLPH),
and Solazyme Inc. (NASDAQ:SZYM). Free research on these four companies can be
accessed at: 

http://investor-edge.com/register

Shares in Horizon Pharma Inc. finished the day at $13.33, down 1.84%, hitting
a new 52-week high of $14.27 on Tuesday. The stock reported a trading volume
of 2.59 million shares during the trading session compared with the
three-month average volume of 1.79 million shares. Horizon Pharma Inc.'s
shares gained 74.93% on YTD basis. Shares of the company have rallied 33.17%
in the last one month and 101.66% in the previous three months. The S&P 500
Health Care Sector Index mapped a loss of 0.26% during the session while the
same has advanced 9.92% in the previous three months. The stock is trading
above both its 50-day and 200-day moving averages. The company's 50-day moving
average of $9.92 is above the 200-day moving average of $5.21. RSI of the
company was 78.23 at the end of the session. Sign up and read the free notes
on HZNP at:

http://www.Investor-Edge.com/03122014/HZNP/report.pdf

On Tuesday, Norfolk Southern Corp.'s stock gained 1.40%, finishing the day at
$95.75, after hitting a new 52-week high of $95.99. The stock recorded a
trading volume of 2.88 million shares, compared with the three-month average
volumes of 2.15 million shares. The company's shares traded at a PE ratio of
16.39 and were up 3.15% on YTD basis. Shares of Norfolk Southern Corp. have
advanced 1.32% in the past three trading sessions and 8.73% in the previous
three months. The stock also witnessed a gain of 2.84% in the last one month.
The S&P 500 Industrials Sector Index mapped a loss of 0.68% during the session
while it charted up by 5.11% during the previous three months. The stock is
trading above its 50-day and 200-day moving averages. Norfolk Southern Corp.'s
50-day moving average of $91.69 is above the 200-day moving average of $82.35.
Furthermore, the company's shares were trading at the Relative Strength Index
(RSI) of 60.13. The complimentary notes on NSC can be downloaded as in PDF
format at:

http://www.Investor-Edge.com/03122014/NSC/report.pdf

Delphi Automotive PLC's stock traded in the range of $66.87 and $67.92,
hitting a new 52-week high of $67.92. The company's stock reported a gain of
1.36%, ending the day at $67.77. A total of 3.30 million shares were traded,
which is above the three months average volume of 1.93 million. The company's
shares have advanced 7.62% in the last one month and 17.55% in the previous
three months. The company stocks traded at a PE ratio of 15.49 and were up
12.71% on YTD basis. The S&P 500 Consumer Discretionary Sector Index posted
gains of 3.33% in the last one month and 3.65% in the previous three months.
The company's stock is trading above both its 50-day and 200-day moving
averages. Delphi Automotive PLC's 50-day moving average of $62.73 is above the
200-day moving average of $57.26. The stock is trading at RSI of 65.34.
Register for free on Investor-Edge and access the latest research on DLPH at:

http://www.Investor-Edge.com/03122014/DLPH/report.pdf

On Tuesday, Solazyme Inc.'s rallied 6.82%, to close the day at $14.41, hitting
a new 52-week high of $14.44. The stock recorded a trading volume of 2.28
million shares, compared with the three-month average volume of 0.97 million
shares. Solazyme Inc.'s shares advanced 32.32% on YTD basis. Shares of the
company have surged 11.75% in the past three trading sessions and 69.33% in
the previous three months. The stock has witnessed a gain of 29.70% in the
last one month. The S&P 500 Energy Sector Index mapped a loss of 1.17% during
the session while the same has advanced 2.58% in the last one month. The stock
is trading above its 50-day and 200-day moving averages. The company's 50-day
moving average of $11.20 is above the 200-day moving average of $10.90.
Furthermore, shares of the company were trading at the Relative Strength Index
(RSI) of 69.88. The complete research on SZYM is available for free at:

http://www.Investor-Edge.com/03122014/SZYM/report.pdf

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to
leverage our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and analysis
of the complexities contained in each situation. That's where Investor-Edge
comes in. We provide a single unified platform for investors' to hear about
what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES:

=============

  oThis is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
  oInformation in this release is fact checked and produced on a best efforts
    basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
  oThis information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
  oIf you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at pubco [at]
    Investor-edge.com.
  oFor any urgent concerns or inquiries, please contact us at compliance [at]
    Investor-edge.com.
  oAre you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to research [at]
    Investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Investor-edge. An
outsourced research services provider represented by Nidhi Vatsal, CFA, has
only reviewed the information provided by Investor-edge in this article or
report according to the Procedures outlined by Investor-edge. Investor-edge is
not entitled to veto or interfere in the application of such procedures by the
outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-edge makes no warranty, expressed or implied, as to the accuracy or
completeness or fitness for a purpose (investment or otherwise), of the
information provided in this document. This information is not to be construed
as personal financial advice. Readers are encouraged to consult their personal
financial advisor before making any decisions to buy, sell or hold any
securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-edge is not responsible for any error which may be occasioned at the
time of printing of this document or any error, mistake or shortcoming. No
liability is accepted by Investor-edge whatsoever for any direct, indirect or
consequential loss arising from the use of this document. Investor-edge
expressly disclaims any fiduciary responsibility or liability for any
consequences, financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee the
accuracy, timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The included
information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

SOURCE Investor-Edge

Contact: CONTACT PERSON: Adam Redford CONTACT PHONE: +852-8191-3972
 
Press spacebar to pause and continue. Press esc to stop.